The DOI matches its Crossref record; 180 of the 180 references it cites were found in a registry or an index.
Tumor angiogenesis: MMP-mediated induction of intravasation- and metastasis-sustaining neovasculature
Open accessAbstract
Metastasis is a distinct stage of cancer progression that requires the development of angiogenic blood vessels serving as conduits for tumor cell dissemination. An accumulated body of evidence indicates that metastasis-supporting neovasculature should possess certain structural characteristics allowing for the process of tumor cell intravasation, an active entry of cancer cells into the vessel interior. It appears that the development of tumor vessels with lumens of a distinctive size and support of these vessels by a discontinuous pericyte coverage constitute critical microarchitectural requirements to: (a) provide accessible points for vessel wall penetration by primary tumor cells; (b) provide enough lumen space for a tumor cell or cell aggregate upon intravasation; and (c) allow for sufficient rate of blood flow to carry away intravasated cells from the primary tumor to the next, proximal or distal site. This review will primarily focus on the functional roles of matrix metalloproteinases (MMPs), which catalytically trigger the development of an intravasation-sustaining neovasculature at the early stages of tumor growth and are also required for the maintenance of a metastasis-supporting state of blood vessels at later stages of cancer progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
The biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591
Microenvironmental regulation of tumor progression and metastasis
Quail, D. F., & Joyce, J. A. (2013) · Nature Medicine · doi:10.1038/nm.3394 · Cited by 7,994
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527 · cited 1×
“…flow are among the “normalization” responses of tumor-associated vasculature to antiangiogenic therapies (Carmeliet and Jain, 2011; Goel et al., 2011; Jain, 2005), which can lead to accelerated tumor progression and enhanced distant metastasis (Ebos et al., 2009; Loges et al., 2009; Paez-Ribes et…”
BackgroundMacrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
Tumor Metastasis: Molecular Insights and Evolving Paradigms
Valastyan, S., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.09.024 · Cited by 4,011
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
Fridlender, Z. G., Sun, J., Kim, S., Kapoor, V., Cheng, G., Ling, L., Worthen, G. S., & Albelda, S. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.06.017 · Cited by 3,371
Neutrophils in the activation and regulation of innate and adaptive immunity
Mantovani, A., Cassatella, M. A., Costantini, C., & Jaillon, S. (2011) · Nature Reviews Immunology · doi:10.1038/nri3024 · Cited by 3,027
Modes of resistance to anti-angiogenic therapy
Bergers, G., & Hanahan, D. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2442 · Cited by 2,953 · cited 2×
“…lack of substantial benefits of anti-VEGF therapies attributed to resistance, adaptation and normalization of tumor vasculature in cancer patients (Bergers and Hanahan, 2008; Claes et al., 2008; Goel et al., 2011; Mancuso et al., 2006; Shojaei et al., 2007; Welti et al., 2013), has clearly…”
BackgroundMatrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., et al. (2000) · Nature Cell Biology · doi:10.1038/35036374 · Cited by 2,797 · cited 7×
“induced the angiogenic switching in avascular pre-malignant tumors (Bergers et al., 2000).”
BackgroundInfluentialPàez-Ribes, M., Allen, E., Hudock, J., Takeda, T., Okuyama, H., Viñals, F., Inoue, M., Bergers, G., Hanahan, D., & Casanovas, O. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.027 · Cited by 2,339
Transcriptional regulation of macrophage polarization: enabling diversity with identity
Lawrence, T., & Natoli, G. (2011) · Nature Reviews Immunology · doi:10.1038/nri3088 · Cited by 2,284
The Interleukin-8 Pathway in Cancer
Waugh, D. J. J., & Wilson, C. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4843 · Cited by 2,103
Matrix metalloproteinases and tumor metastasis
Deryugina, E. I., & Quigley, J. P. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-7886-9 · Cited by 1,960
Self-citationInduction of angiogenesis during the transition from hyperplasia to neoplasia
Folkman, J., Watson, K., Ingber, D., & Hanahan, D. (1989) · Nature · doi:10.1038/339058a0 · Cited by 1,879
Vascular Endothelial Growth Factor and Angiogenesis
Hoeben, A., Landuyt, B., Highley, M. S., Wildiers, H., Van Oosterom, A. T., & De Bruijn, E. A. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.4.3 · Cited by 1,824
Tumor angiogenesis: molecular pathways and therapeutic targets
Weis, S. M., & Cheresh, D. A. (2011) · Nature Medicine · doi:10.1038/nm.2537 · Cited by 1,736
Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
Ebos, J. M. L., Lee, C. R., Cruz-Munoz, W., Bjarnason, G. A., Christensen, J. G., & Kerbel, R. S. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.021 · Cited by 1,709
Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
Carmeliet, P., & Jain, R. K. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3455 · Cited by 1,675
VEGF-targeted therapy: mechanisms of anti-tumour activity
Ellis, L. M., & Hicklin, D. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2403 · Cited by 1,673
Normalization of the Vasculature for Treatment of Cancer and Other Diseases
Goel, S., Duda, D. G., Xu, L., Munn, L. L., Boucher, Y., Fukumura, D., & Jain, R. K. (2011) · Physiological Reviews · doi:10.1152/physrev.00038.2010 · Cited by 1,605
Integrin-regulated FAK–Src signaling in normal and cancer cells
Mitra, S. K., & Schlaepfer, D. D. (2006) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2006.08.011 · Cited by 1,590
Takahashi, Y., Kitadai, Y., Bucana, C. D., Cleary, K. R., & Ellis, L. M. (1995) · PubMed · Cited by 1,265
Goel, H. L., & Mercurio, A. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3627 · Cited by 1,253
Tumors as Organs: Complex Tissues that Interface with the Entire Organism
Egeblad, M., Nakasone, E. S., & Werb, Z. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.05.012 · Cited by 1,234
Du, R., Lu, K. V., Petritsch, C., Liu, P., Ganss, R., Passegué, E., Song, H., VandenBerg, S., Johnson, R. S., Werb, Z., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.01.034 · Cited by 1,130
Houck, K. A., Leung, D. W., Rowland, A. M., Winer, J., & Ferrara, N. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35712-0 · Cited by 1,127
Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis
Coussens, L. M., Raymond, W. W., Bergers, G., Laig-Webster, M., Behrendtsen, O., Werb, Z., Caughey, G. H., & Hanahan, D. (1999) · Genes & Development · doi:10.1101/gad.13.11.1382 · Cited by 946 · cited 1×
“By using mast cell-deficient transgenic mice, the infiltration by mast cells delivering MMP-9activating proteases was linked to the MMP-9-mediated angiogenic switch and resulting tumor angiogenesis in the skin carcinogenesis model (Coussens et al., 1999).”
BackgroundNozawa, H., Chiu, C., & Hanahan, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601807103 · Cited by 923
Hiratsuka, S., Nakamura, K., Iwai, S., Murakami, M., Itoh, T., Kijima, H., Shipley, J. M., Senior, R. M., & Shibuya, M. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00153-8 · Cited by 910
Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis
Sparmann, A., & Bar-Sagi, D. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.028 · Cited by 851
Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells
Shojaei, F., Wu, X., Malik, A. K., Zhong, C., Baldwin, M. E., Schanz, S., Fuh, G., Gerber, H.-P., & Ferrara, N. (2007) · Nature Biotechnology · doi:10.1038/nbt1323 · Cited by 849 · cited 1×
“…and normalization of tumor vasculature in cancer patients (Bergers and Hanahan, 2008; Claes et al., 2008; Goel et al., 2011; Mancuso et al., 2006; Shojaei et al., 2007; Welti et al., 2013), has clearly indicated that the functional activities of VEGF molecule are more broad and complex than its…”
BackgroundBoire, A., Covic, L., Agarwal, A., Jacques, S., Sherifi, S., & Kuliopulos, A. (2005) · Cell · doi:10.1016/j.cell.2004.12.018 · Cited by 838
Mazzone, M., Dettori, D., Leite de Oliveira, R., Loges, S., Schmidt, T., Jonckx, B., Tian, Y.-M., Lanahan, A. A., Pollard, P., Ruiz de Almodovar, C., et al. (2009) · Cell · doi:10.1016/j.cell.2009.01.020 · Cited by 812
Rapid vascular regrowth in tumors after reversal of VEGF inhibition
Mancuso, M. R., Davis, R., Norberg, S. M., O'Brien, S., Sennino, B., Nakahara, T., Yao, V. J., Inai, T., Brooks, P., Freimark, B., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci24612 · Cited by 809
The neutrophil as a cellular source of chemokines
Scapini, P., Lapinet‐Vera, J. A., Gasperini, S., Calzetti, F., Bazzoni, F., & Cassatella, M. A. (2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.17706.x · Cited by 802
The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis
Brat, D. J., Bellail, A. C., & Van Meir, E. G. (2005) · Neuro-Oncology · doi:10.1215/s1152851704001061 · Cited by 760
Developmental and Pathological Angiogenesis
Chung, A. S., & Ferrara, N. (2011) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-154002 · Cited by 722
Hypoxia: A key regulator of angiogenesis in cancer
Liao, D., & Johnson, R. S. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9066-y · Cited by 721
Tumor-Associated Neutrophils: New Targets for Cancer Therapy
Gregory, A. D., & McGarry Houghton, A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2583 · Cited by 707
Lee, S., Jilani, S. M., Nikolova, G. V., Carpizo, D., & Iruela-Arispe, M. L. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200409115 · Cited by 703
Giraudo, E., Inoue, M., & Hanahan, D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422087 · Cited by 700
Warren, R. S., Yuan, H., Matli, M. R., Gillett, N. A., & Ferrara, N. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117857 · Cited by 694
Van den Steen, P. E., Proost, P., Wuyts, A., Van Damme, J., & Opdenakker, G. (2000) · Blood · doi:10.1182/blood.v96.8.2673 · Cited by 680
Qian, B., Deng, Y., Im, J. H., Muschel, R. J., Zou, Y., Li, J., Lang, R. A., & Pollard, J. W. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006562 · Cited by 664
Gelatinase-mediated migration and invasion of cancer cells
Björklund, M., & Koivunen, E. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.03.001 · Cited by 661
A role for VEGF as a negative regulator of pericyte function and vessel maturation
Greenberg, J. I., Shields, D. J., Barillas, S. G., Acevedo, L. M., Murphy, E., Huang, J., Scheppke, L., Stockmann, C., Johnson, R. S., Angle, N., et al. (2008) · Nature · doi:10.1038/nature07424 · Cited by 629
Casazza, A., Laoui, D., Wenes, M., Rizzolio, S., Bassani, N., Mambretti, M., Deschoemaeker, S., Van Ginderachter, J. A., Tamagnone, L., & Mazzone, M. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.11.007 · Cited by 629
Zeisberger, S. M., Odermatt, B., Marty, C., Zehnder-Fjällman, A. H. M., Ballmer-Hofer, K., & Schwendener, R. A. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603240 · Cited by 623
Fleming, T. J., Fleming, M. L., & Malek, T. R. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.5.2399 · Cited by 619
Ardi, V. C., Kupriyanova, T. A., Deryugina, E. I., & Quigley, J. P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706438104 · Cited by 602
Self-citationRecent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer
Welti, J., Loges, S., Dimmeler, S., & Carmeliet, P. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70212 · Cited by 591
Jablonska, J., Leschner, S., Westphal, K., Lienenklaus, S., & Weiss, S. (2010) · Journal of Clinical Investigation · doi:10.1172/jci37223 · Cited by 564
Okada, Y., Gonoji, Y., Naka, K., Tomita, K., Nakanishi, I., Iwata, K., Yamashita, K., & Hayakawa, T. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36670-0 · Cited by 501
Kuang, D.-M., Zhao, Q., Wu, Y., Peng, C., Wang, J., Xu, Z., Yin, X.-Y., & Zheng, L. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.08.041 · Cited by 499
Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis
Stockmann, C., Doedens, A., Weidemann, A., Zhang, N., Takeda, N., Greenberg, J. I., Cheresh, D. A., & Johnson, R. S. (2008) · Nature · doi:10.1038/nature07445 · Cited by 471
Tumor associated macrophages and neutrophils in tumor progression
Galdiero, M. R., Garlanda, C., Jaillon, S., Marone, G., & Mantovani, A. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24260 · Cited by 440
The cell biology of leukocyte-mediated proteolysis
Owen, C. A., & Campbell, E. J. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.65.2.137 · Cited by 439
De Larco, J. E., Wuertz, B. R. K., & Furcht, L. T. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0760 · Cited by 412
Sennino, B., Ishiguro-Oonuma, T., Wei, Y., Naylor, R. M., Williamson, C. W., Bhagwandin, V., Tabruyn, S. P., You, W.-K., Chapman, H. A., Christensen, J. G., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0240 · Cited by 408
Silencing or Fueling Metastasis with VEGF Inhibitors: Antiangiogenesis Revisited
Loges, S., Mazzone, M., Hohensinner, P., & Carmeliet, P. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.02.007 · Cited by 393
Pericytes and vessel maturation during tumor angiogenesis and metastasis
Raza, A., Franklin, M. J., & Dudek, A. Z. (2010) · American Journal of Hematology · doi:10.1002/ajh.21745 · Cited by 382
Dumitru, C. A., Moses, K., Trellakis, S., Lang, S., & Brandau, S. (2012) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-012-1294-5 · Cited by 374
Zhang, W., Zhu, X.-D., Sun, H.-C., Xiong, Y.-Q., Zhuang, P.-Y., Xu, H.-X., Kong, L.-Q., Wang, L., Wu, W.-Z., & Tang, Z.-Y. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2904 · Cited by 374
On the dual roles and polarized phenotypes of neutrophils in tumor development and progression
Piccard, H., Muschel, R. J., & Opdenakker, G. (2012) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2011.06.004 · Cited by 373
The metastasis-promoting roles of tumor-associated immune cells
Smith, H. A., & Kang, Y. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1021-5 · Cited by 367
Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice
Sawanobori, Y., Ueha, S., Kurachi, M., Shimaoka, T., Talmadge, J. E., Abe, J., Shono, Y., Kitabatake, M., Kakimi, K., Mukaida, N., et al. (2008) · Blood · doi:10.1182/blood-2008-01-136895 · Cited by 367
Bar-Or, A. (2003) · Brain · doi:10.1093/brain/awg285 · Cited by 360
Huang, S. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.15.1134 · Cited by 349
VEGF-A and Tenascin-C produced by S100A4 + stromal cells are important for metastatic colonization
O'Connell, J. T., Sugimoto, H., Cooke, V. G., MacDonald, B. A., Mehta, A. I., LeBleu, V. S., Dewar, R., Rocha, R. M., Brentani, R. R., Resnick, M. B., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109493108 · Cited by 348 · cited 2×
“…broad and complex than its direct effects on the endothelium or indirect influencing of vascular pericytes and might overlap with multiple molecular networks and processes (Dawson et al., 2009; Garmy-Susini et al., 2010; Mazzone et al., 2009; Mitra and Schlaepfer, 2006; O’Connell et al., 2011).”
BackgroundCoffelt, S. B., Tal, A. O., Scholz, A., De Palma, M., Patel, S., Urbich, C., Biswas, S. K., Murdoch, C., Plate, K. H., Reiss, Y., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0012 · Cited by 343
Inhibition of tumor growth by elimination of granulocytes.
Pekarek, L. A., Starr, B. A., Toledano, A. Y., & Schreiber, H. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.1.435 · Cited by 340
Interstitial collagenases as markers of tumor progression.
Brinckerhoff, C., Rutter, J. L., & Benbow, U. (2000) · PubMed · Cited by 339
Hashimoto, G., Inoki, I., Fujii, Y., Aoki, T., Ikeda, E., & Okada, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201674200 · Cited by 339
Inflammatory macrophage migration requires MMP-9 activation by plasminogen in mice
Gong, Y., Hart, E., Shchurin, A., & Hoover-Plow, J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32750 · Cited by 334
Role of Bv8 in neutrophil-dependent angiogenesis in a transgenic model of cancer progression
Shojaei, F., Singh, M., Thompson, J. D., & Ferrara, N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712185105 · Cited by 334
Tumour macrophages as potential targets of bisphosphonates
Rogers, T. L., & Holen, I. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-177 · Cited by 324
Neutrophils: key mediators of tumour angiogenesis
Tazzyman, S., Lewis, C. E., & Murdoch, C. (2009) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2009.00641.x · Cited by 318
Belotti, D., Paganoni, P., Manenti, L., Garofalo, A., Marchini, S., Taraboletti, G., & Giavazzi, R. (2003) · PubMed · Cited by 318
Byrne, A. T., Ross, L. H., Holash, J., Nakanishi, M., Hu, L., Hofmann, J., Yancopoulos, G. D., & Jaffe, R. B. (2003) · PubMed · Cited by 310
Zheng, H., Takahashi, H., Murai, Y., Cui, Z., Nomoto, K., Niwa, H., Tsuneyama, K., & Takano, Y. (2006) · PubMed · Cited by 305
Deryugina, E. I., Zajac, E., Juncker-Jensen, A., Kupriyanova, T. A., Welter, L., & Quigley, J. P. (2014) · Neoplasia · doi:10.1016/j.neo.2014.08.013 · Cited by 304
Self-citationBekes, E. M., Schweighofer, B., Kupriyanova, T. A., Zajac, E., Ardi, V. C., Quigley, J. P., & Deryugina, E. I. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.05.031 · Cited by 298
Self-citationTumor Microenvironment in Head and Neck Squamous Cell Carcinoma
Curry, J. M., Sprandio, J., Cognetti, D., Luginbuhl, A., Bar-ad, V., Pribitkin, E., & Tuluc, M. (2014) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.03.003 · Cited by 293
Pore, N., Jiang, Z., Gupta, A., Cerniglia, G., Kao, G. D., & Maity, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3090 · Cited by 268
Sounni, N. E., Devy, L., Hajitou, A., Frankenne, F., Munaut, C., Gilles, C., Deroanne, C., Thompson, E. W., Foidart, J. M., & Noel, A. (2002) · The FASEB Journal · doi:10.1096/fj.01-0790com · Cited by 260
Zajac, E., Schweighofer, B., Kupriyanova, T. A., Juncker-Jensen, A., Minder, P., Quigley, J. P., & Deryugina, E. I. (2013) · Blood · doi:10.1182/blood-2013-05-501494 · Cited by 260
Self-citationAngiogenesis and prostate cancer: identification of a molecular progression switch.
Huss, W. J., Hanrahan, C. F., Barrios, R. J., Simons, J. W., & Greenberg, N. M. (2001) · PubMed · Cited by 253
Scapini, P., Morini, M., Tecchio, C., Minghelli, S., Di Carlo, E., Tanghetti, E., Albini, A., Lowell, C., Berton, G., Noonan, D. M., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.8.5034 · Cited by 249
Kiriakidis, S., Andreakos, E., Monaco, C., Foxwell, B., Feldmann, M., & Paleolog, E. (2003) · Journal of Cell Science · doi:10.1242/jcs.00286 · Cited by 235
Huang, J., Frischer, J. S., Serur, A., Kadenhe, A., Yokoi, A., McCrudden, K. W., New, T., O'Toole, K., Zabski, S., Rudge, J. S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432908100 · Cited by 227
De Francesco, E. M., Lappano, R., Santolla, M. F., Marsico, S., Caruso, A., & Maggiolini, M. (2013) · Breast Cancer Research · doi:10.1186/bcr3458 · Cited by 227
Chantrain, C. F., Shimada, H., Jodele, S., Groshen, S., Ye, W., Shalinsky, D. R., Werb, Z., Coussens, L. M., & DeClerck, Y. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0160 · Cited by 218
Vessel abnormalization: another hallmark of cancer?
De Bock, K., Cauwenberghs, S., & Carmeliet, P. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.10.008 · Cited by 213
VEGF release by MMP-9 mediated heparan sulphate cleavage induces colorectal cancer angiogenesis
Hawinkels, L. J. A. C., Zuidwijk, K., Verspaget, H. W., de Jonge-Muller, E. S. M., Duijn, W. V., Ferreira, V., Fontijn, R. D., David, G., Hommes, D. W., Lamers, C. B. H. W., et al. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.06.031 · Cited by 211
Roles of Matrix Metalloproteinases and Their Natural Inhibitors in Prostate Cancer Progression
Gong, Y., Chippada-Venkata, U., & Oh, W. (2014) · Cancers · doi:10.3390/cancers6031298 · Cited by 211
Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression
Farina, A., & Mackay, A. (2014) · Cancers · doi:10.3390/cancers6010240 · Cited by 206
Kim, S. J., Uehara, H., Karashima, T., Mccarty, M., Shih, N., & Fidler, I. J. (2001) · Neoplasia · doi:10.1038/sj.neo.7900124 · Cited by 206
MMP‐2 alters VEGF expression via αVβ3 integrin‐mediated PI3K/AKT signaling in A549 lung cancer cells
Chetty, C., Lakka, S. S., Bhoopathi, P., & Rao, J. S. (2010) · International Journal of Cancer · doi:10.1002/ijc.25134 · Cited by 205
Ogata, Y., Itoh, Y., & Nagase, H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.31.18506 · Cited by 201
Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype.
Choe, G., Park, J. K., Jouben-Steele, L., Kremen, T. J., Liau, L. M., Vinters, H. V., Cloughesy, T. F., & Mischel, P. S. (2002) · PubMed · Cited by 197
Ellerbroek, S. M., Halbleib, J. M., Benavidez, M., Warmka, J. K., Wattenberg, E. V., Stack, M. S., & Hudson, L. G. (2001) · PubMed · Cited by 193
Xue, C., Wyckoff, J., Liang, F., Sidani, M., Violini, S., Tsai, K.-L., Zhang, Z.-Y., Sahai, E., Condeelis, J., & Segall, J. E. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1242 · Cited by 188
Benelli, R., Morini, M., Carrozzino, F., Ferrari, N., Minghelli, S., Santi, L., Cassatella, M., Noonan, D. M., & Albini, A. (2002) · The FASEB Journal · doi:10.1096/fj.01-0651fje · Cited by 188
Pahler, J. C., Tazzyman, S., Erez, N., Chen, Y.-Y., Murdoch, C., Nozawa, H., Lewis, C. E., & Hanahan, D. (2008) · Neoplasia · doi:10.1593/neo.07871 · Cited by 184
Tazawa, H., Okada, F., Kobayashi, T., Tada, M., Mori, Y., Une, Y., Sendo, F., Kobayashi, M., & Hosokawa, M. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63580-8 · Cited by 178
The paradox of tumor-associated neutrophils: Fueling tumor growth with cytotoxic substances
Houghton, A. M. (2010) · Cell Cycle · doi:10.4161/cc.9.9.11297 · Cited by 166
Elusive Identities and Overlapping Phenotypes of Proangiogenic Myeloid Cells in Tumors
Coffelt, S. B., Lewis, C. E., Naldini, L., Brown, J. M., Ferrara, N., & Palma, M. D. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090786 · Cited by 163
Ardi, V. C., den Steen, P. E. V., Opdenakker, G., Schweighofer, B., Deryugina, E. I., & Quigley, J. P. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.033472 · Cited by 161
Self-citationTan, K. W., Chong, S. Z., Wong, F. H. S., Evrard, M., Tan, S. M.-L., Keeble, J., Kemeny, D. M., Ng, L. G., Abastado, J.-P., & Angeli, V. (2013) · Blood · doi:10.1182/blood-2012-11-466532 · Cited by 160
O‐charoenrat, P., Modjtahedi, H., Rhys‐Evans, P., Court, W. J., Box, G., & Eccles, S. A. (2000) · PubMed · Cited by 159
Bausch, D., Pausch, T. M., Krauß, T., Hopt, U. T., Fernández‐del‐Castillo, C., Warshaw, A. L., Thayer, S. P., & Keck, T. (2011) · Angiogenesis · doi:10.1007/s10456-011-9207-3 · Cited by 159
Jodele, S., Chantrain, C. F., Blavier, L., Lutzko, C., Crooks, G. M., Shimada, H., Coussens, L. M., & DeClerck, Y. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3770 · Cited by 159
Integrin α4β1 Signaling Is Required for Lymphangiogenesis and Tumor Metastasis
Garmy-Susini, B., Avraamides, C. J., Schmid, M. C., Foubert, P., Ellies, L. G., Barnes, L., Feral, C., Papayannopoulou, T., Lowy, A., Blair, S. L., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3761 · Cited by 158
Deryugina, E. I., Soroceanu, L., & Strongin, A. Y. (2002) · PubMed · Cited by 158
Self-citationMatrix Metalloproteinase-13 (MMP-13) Directly and Indirectly Promotes Tumor Angiogenesis
Kudo, Y., Iizuka, S., Yoshida, M., Tsunematsu, T., Kondo, T., Subarnbhesaj, A., Deraz, E. M., Siriwardena, B. S. M. S., Tahara, H., Ishimaru, N., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.373159 · Cited by 156
A Critical Role for Macrophages in Promotion of Urethane-Induced Lung Carcinogenesis
Zaynagetdinov, R., Sherrill, T. P., Polosukhin, V. V., Han, W., Ausborn, J. A., McLoed, A. G., McMahon, F. B., Gleaves, L. A., Degryse, A. L., Stathopoulos, G. T., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100558 · Cited by 156
Mira, E., Lacalle, R. A., Buesa, J. M., de Buitrago, G. G., Jiménez-Baranda, S., Gómez‐Moutón, C., Martínez‐A, C., & Mañes, S. (2004) · Journal of Cell Science · doi:10.1242/jcs.01035 · Cited by 155
Neutrophil-mediated tumour angiogenesis: Subversion of immune responses to promote tumour growth
Tazzyman, S. J., Niaz, H. A., & Murdoch, C. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.02.003 · Cited by 153
Yang, E., Boire, A. A., Agarwal, A., Nguyen, N., O’Callaghan, K., Tu, P., Kuliopulos, A., & Covic, L. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0187 · Cited by 149
Mechanisms of pericyte recruitment in tumour angiogenesis: A new role for metalloproteinases
Chantrain, C. F., Henriet, P., Jodele, S., Emonard, H., Féron, O., Courtoy, P. J., DeClerck, Y. A., & Marbaix, É. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2005.11.010 · Cited by 144
Vascular permeability changes involved in tumor metastasis
García-Román, J., & Zentella‐Dehesa, A. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.03.005 · Cited by 142
Sounni, N. E., Roghi, C., Chabottaux, V., Janssen, M., Munaut, C., Maquoi, E., Gálvez, B. G., Gilles, C., Frankenne, F., Murphy, G., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307688200 · Cited by 140
The VEGF angiogenic switch of fibroblasts is regulated by MMP-7 from cancer cells
Ito, T.-K., Ishii, G., Chiba, H., & Ochiai, A. (2007) · Oncogene · doi:10.1038/sj.onc.1210535 · Cited by 136
Green, C. E., Liu, T., Montel, V., Hsiao, G., Lester, R. D., Subramaniam, S., Gonias, S. L., & Klemke, R. L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006713 · Cited by 135
Cutting Edge: Proangiogenic Properties of Alternatively Activated Dendritic Cells
Riboldi, E., Musso, T., Moroni, E., Urbinati, C., Bernasconi, S., Rusnati, M., Adorini, L., Presta, M., & Sozzani, S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.5.2788 · Cited by 134
MMP13 as a stromal mediator in controlling persistent angiogenesis in skin carcinoma
Lederle, W., Hartenstein, B., Meides, A., Kunzelmann, H., Werb, Z., Angel, P. E., & Mueller, M. M. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp248 · Cited by 134
Interleukin‐8 modulates growth and invasiveness of estrogen receptor‐negative breast cancer cells
Yao, C., Lin, Y., Chua, M., Ye, C., Bi, J., Li, W., Zhu, Y., & Wang, S. (2007) · International Journal of Cancer · doi:10.1002/ijc.22930 · Cited by 132
Du, R., Petritsch, C. K., Lu, K. V., Liu, P., Haller, A., Ganß, R., Song, H., VandenBerg, S. R., & Bergers, G. (2008) · Neuro-Oncology · doi:10.1215/15228517-2008-001 · Cited by 132
Cerniglia, G. J., Pore, N., Tsai, J. H., Schultz, S. M., Mick, R., Choe, R., Xing, X., Durduran, T., Yodh, A. G., Evans, S. M., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006539 · Cited by 132
p53, vessel count, and vascular endothelial growth factor expression in human colon cancer
Takahashi, Y., Bucana, C. D., Cleary, K. R., & Ellis, L. M. (1998) · International Journal of Cancer · Cited by 126
Tressel, S. L., Kaneider, N. C., Kasuda, S., Foley, C., Κούκος, Γ., Austin, K. M., Agarwal, A., Covic, L., Opal, S. M., & Kuliopulos, A. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201100145 · Cited by 126
Ebrahem, Q., Chaurasia, S. S., Vasanji, A., Qi, J. H., Klenotic, P. A., Cutler, A., Asosingh, K., ERZURUM, S. C., & Anand‐Apte, B. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2010.080642 · Cited by 123
Hwang, Y. P., Yun, H. J., Choi, J. H., Han, E. H., Kim, H. G., Song, G., Kwon, K., Jeong, T. C., & Jeong, H. G. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201000292 · Cited by 121
Extratumoral Macrophages Promote Tumor and Vascular Growth in an Orthotopic Rat Prostate Tumor Model
Bergström, S. H., Rudolfsson, S. H., van Rooijen, N., & Bergh, A. R. J. (2009) · Neoplasia · doi:10.1593/neo.81338 · Cited by 112
Juncker‐Jensen, A., Deryugina, E. I., Rimann, I., Zając, E., Kupriyanova, T. A., Engelholm, L. H., & Quigley, J. P. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4495 · Cited by 106
Self-citationAntiangiogenic compounds interfere with chemotherapy of brain tumors due to vessel normalization
Claes, A., Wesseling, P., Jeuken, J. W. M., Maass, C., Heerschap, A., & Leenders, W. P. J. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0552 · Cited by 105
Zhang, G., Miyake, M., Lawton, A., Goodison, S., & Rosser, C. J. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-310 · Cited by 101
Inflammation Induced by MMP-9 Enhances Tumor Regression of Experimental Breast Cancer
Leifler, K. S., Svensson, S., Abrahamsson, A. E., Bendrik, C., Robertson, J. V., Gauldie, J., Olsson, A., & Dabrosin, C. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202610 · Cited by 100
Deryugina, E. I., Zijlstra, A., Partridge, J. J., Kupriyanova, T. A., Madsen, M. A., Papagiannakopoulos, T. Y., & Quigley, J. P. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2228 · Cited by 94
Self-citationKanai, T., Konno, H., Tanaka, T., Baba, M., Matsumoto, K., Nakamura, S., Yukita, A., Asano, M., Suzuki, H., & Baba, S. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980911)77:6<933::aid-ijc23>3.0.co;2-0 · Cited by 93
Kim, S., Choi, J. H., Lim, H. I., Lee, S.-K., Kim, W. W., Cho, S., Kim, J. S., Kim, J., Choe, J., Nam, S. J., et al. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.01.034 · Cited by 92
Yu, W., Chen, L., Yang, Y.-Q., Falck, J. R., Guo, A. M., Li, Y., & Yang, J. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-010-1521-8 · Cited by 92
Monocyte Subpopulations in Angiogenesis
Dalton, H. J., Armaiz-Peña, G. N., González-Villasana, V., Lopez‐Berestein, G., Bar‐Eli, M., & Sood, A. K. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2825 · Cited by 89
Owen, J. L., Iragavarapu‐Charyulu, V., Gunja‐Smith, Z., Herbert, L. M., Grosso, J. F., & Lopez, D. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.8.4340 · Cited by 89
Haqqani, A. S., Sandhu, J. K., & Birnboim, H. C. (2000) · Neoplasia · doi:10.1038/sj.neo.7900110 · Cited by 88
Schruefer, R., Lutze, N., Schymeinsky, J., & Walzog, B. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00237.2004 · Cited by 88
Mazor, R., Alsaigh, T., Shaked, H., Altshuler, A. E., Pocock, E. S., Kistler, E. B., Karin, M., & Schmid‐Schönbein, G. W. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.417451 · Cited by 86
Zijlstra, A., Seandel, M., Kupriyanova, T. A., Partridge, J. J., Madsen, M. A., Hahn-Dantona, E. A., Quigley, J. P., & Deryugina, E. I. (2005) · Blood · doi:10.1182/blood-2005-04-1458 · Cited by 86
Self-citationTaguchi, A., Kawana, K., Tomio, K., Yamashita, A., Isobe, Y., Nagasaka, K., Koga, K., Inoue, T., Nishida, H., Kojima, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089605 · Cited by 85
Sithu, S. D., English, W., Olson, P. R., Krubasik, D., Baker, A. H., Murphy, G., & D’Souza, S. E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611273200 · Cited by 85
Targeting EGFR resistance networks in head and neck cancer
Ratushny, V., Astsaturov, I. A., Burtness, B. A., Golemis, E. A., & Silverman, J. S. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.02.021 · Cited by 83
Vempati, P., Gabhann, F. M., & Popel, A. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011860 · Cited by 77
VEGFR1-activity-independent metastasis formation
Dawson, M., Duda, D. G., Fukumura, D., & Jain, R. K. (2009) · Nature · doi:10.1038/nature08254 · Cited by 77
Elpek, K. G., Cremasco, V., Shen, H., Harvey, C. J., Wucherpfennig, K. W., Goldstein, D. R., Monach, P. A., & Turley, S. J. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0209 · Cited by 77
Bruni‐Cardoso, A., Johnson, L. C., Vessella, R. L., Peterson, T. E., & Lynch, C. C. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0445 · Cited by 74
Zhang, J., Chen, G., Liu, Y., Wang, P., Wang, X., Wan, Y., Zhu, J., Gao, H., Yin, J., Wang, W., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044618 · Cited by 69
Kaimal, R., Aljumaily, R. M., Tressel, S. L., Pradhan, R. V., Covic, L., Kuliopulos, A., Zarwan, C., Kim, Y. B., Sharifi, S., & Agarwal, A. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-1426 · Cited by 69
Kim, J., Thorne, S. H., Sun, L., Huang, B., & Mochly‐Rosen, D. (2010) · Oncogene · doi:10.1038/onc.2010.415 · Cited by 68
Polymorphonuclear neutrophils promote rFGF-2-induced angiogenesis in vivo
Shaw, J. P., Chuang, N., Yee, H. T., & Shamamian, P. E. (2003) · Journal of Surgical Research · doi:10.1016/s0022-4804(02)00020-3 · Cited by 64
Neutrophil Depletion Decreases VEGF-Induced Focal Angiogenesis in the Mature Mouse Brain
Qi, H., Chen, Y., Zhu, Y., Fan, Y., Palmer, D., Su, H., Young, W. L., & Yang, G. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600485 · Cited by 60
Wang, S., Liu, H., Ren, L., Pan, Y., & Zhang, Y. (2008) · Neoplasia · doi:10.1593/neo.07613 · Cited by 58
Normanno, N., & Gullick, W. J. (2006) · Endocrine Related Cancer · doi:10.1677/erc.1.01185 · Cited by 58
An Extensive Invasive Intracranial Human Glioblastoma Xenograft Model
Zhao, Y., Xiao, A., diPierro, C. G., Carpenter, J. E., Abdel‐Fattah, R., Redpath, G. T., Lopes, M.-B. S., & Hussaini, I. M. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090571 · Cited by 56
Leukocytes as paracrine regulators of metastasis and determinants of organ‐specific colonization
Erez, N., & Coussens, L. M. (2011) · International Journal of Cancer · doi:10.1002/ijc.26032 · Cited by 50
CD13-positive bone marrow-derived myeloid cells promote angiogenesis, tumor growth, and metastasis
Dondossola, E., Rangel, R., Guzman‐Rojas, L., Barbu, E. M., Hosoya, H., John, L. S. S., Molldrem, J. J., Corti, A., Sidman, R. L., Arap, W., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321139110 · Cited by 50
The role of MMP-9 in the anti-angiogenic effect of secreted protein acidic and rich in cysteine
Bhoopathi, P., Chetty, C., Gujrati, M., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605538 · Cited by 41
Partridge, J. J., Madsen, M. A., Ardi, V. C., Papagiannakopoulos, T. Y., Kupriyanova, T. A., Quigley, J. P., & Deryugina, E. I. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705993200 · Cited by 39
Self-citationKahlert, C., Pecqueux, M., Halama, N., Dienemann, H., Muley, T., Pfannschmidt, J., Lasitschka, F., Klupp, F., Schmidt, T., Rahbari, N. N., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.745 · Cited by 36
Ugarte-Berzal, E., Redondo-Muñóz, J., Eroles, P., del Cerro, M. H., Garcia-Marco, J. A., Terol, M. J., & Garcı́a-Pardo, A. (2009) · Blood · doi:10.1182/blood-2009-08-239426 · Cited by 34
Woenne, E. C., Lederle, W., Zwick, S., Palmowski, M., Krell, H. W., Semmler, W., Mueller, M. M., & Kiessling, F. M. (2010) · PubMed · Cited by 32
Deryugina, E. I. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3628-1_19 · Cited by 24
Self-citationDepner, S., Lederle, W., Gutschalk, C. M., Linde, N., Zajonz, A., & Mueller, M. M. (2012) · International Journal of Cancer · doi:10.1002/ijc.27951 · Cited by 23
Rawashdeh, W. A., Arns, S., Gremse, F., Ehling, J., Knüchel‐Clarke, R., Kray, S., Spöler, F., Kiessling, F. M., & Lederle, W. (2014) · Neoplasia · doi:10.1016/j.neo.2014.03.005 · Cited by 14
Chapter 6 Mouse Models to Investigate Anti-Cancer Effects of VEGF Inhibitors
Crawford, Y., & Ferrara, N. (2008) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(08)03006-1 · Cited by 2
Cited by
Kamaly, N., Yameen, B., Wu, J., & Farokhzad, O. C. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00346 · Cited by 3,070
Concepts of extracellular matrix remodelling in tumour progression and metastasis
Winkler, J., Abisoye-Ogunniyan, A., Metcalf, K. J., & Werb, Z. (2020) · Nature Communications · doi:10.1038/s41467-020-18794-x · Cited by 2,296
Spatially organized multicellular immune hubs in human colorectal cancer
Pelka, K., Hofree, M., Chen, J. H., Sarkizova, S., Pirl, J. D., Jorgji, V., Bejnood, A., Dionne, D., Ge, W. H., Xu, K. H., et al. (2021) · Cell · doi:10.1016/j.cell.2021.08.003 · Cited by 874
Matrix Metalloproteinase Inhibitors in Cancer Therapy: Turning Past Failures Into Future Successes
Winer, A., Adams, S., & Mignatti, P. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0646 · Cited by 651
The extracellular matrix in tumor progression and metastasis
Eble, J. A., & Niland, S. (2019) · Clinical & Experimental Metastasis · doi:10.1007/s10585-019-09966-1 · Cited by 613
Metadata
- Authors
- Deryugina, E. I., & Quigley, J. P.
- Venue
- Matrix Biology
- Publisher
- Elsevier BV
- Published
- 2015-05
- Volume
- 44-46
- Pages
- 94-112
- ISSN
- 0945-053X (ISSN-L)
- OpenAlex
- W1975113490
- Cited by
- 422
- References
- 180
- FWCI
- 17.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.